Works matching AU Egeo, Gabriella

Results: 70
    1

    ADAM23, a Gene Related to LGI1, Is Not Linked to Autosomal Dominant Lateral Temporal Epilepsy.

    Published in:
    Epilepsy Research & Treatment, 2011, p. 1, doi. 10.1155/2011/258365
    By:
    • Rigon, Laura;
    • Vettori, Andrea;
    • Busolin, Giorgia;
    • Egeo, Gabriella;
    • Pulitano, Patrizia;
    • Santulli, Lia;
    • Pasini, Elena;
    • Striano, Pasquale;
    • la Neve, Angela;
    • Dri, Valeria Vianello;
    • Boniver, Clementina;
    • Gambardella, Antonio;
    • Banfi, Paola;
    • Binelli, Simona;
    • Di Bonaventura, Carlo;
    • Striano, Salvatore;
    • de Falco, Fabrizio;
    • Giallonardo, Anna T.;
    • Mecarelli, Oriano;
    • Michelucci, Roberto
    Publication type:
    Article
    2

    Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 7, p. 1288, doi. 10.1111/epi.12194
    By:
    • Michelucci, Roberto;
    • Pasini, Elena;
    • Malacrida, Sandro;
    • Striano, Pasquale;
    • Bonaventura, Carlo Di;
    • Pulitano, Patrizia;
    • Bisulli, Francesca;
    • Egeo, Gabriella;
    • Santulli, Lia;
    • Sofia, Vito;
    • Gambardella, Antonio;
    • Elia, Maurizio;
    • Falco, Arturo;
    • Neve, Angela la;
    • Banfi, Paola;
    • Coppola, Giangennaro;
    • Avoni, Patrizia;
    • Binelli, Simona;
    • Boniver, Clementina;
    • Pisano, Tiziana
    Publication type:
    Article
    3
    4
    5

    Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1mutation: electroclinical, genetic, and EEG/fMRI findings.

    Published in:
    Epilepsia (Series 4), 2009, v. 50, n. 11, p. 2481, doi. 10.1111/j.1528-1167.2009.02181.x
    By:
    • Di Bonaventura, Carlo;
    • Carni, Marco;
    • Diani, Erica;
    • Fattouch, Jinane;
    • Vaudano, Elisabetta A.;
    • Egeo, Gabriella;
    • Pantano, Patrizia;
    • Maraviglia, Bruno;
    • Bozzao, Luigi;
    • Manfredi, Mario;
    • Prencipe, Massimiliano;
    • Giallonardo, Teresa A.;
    • Nobile, Carlo
    Publication type:
    Article
    6

    The first report of the Italian Migraine Registry (I-GRAINE).

    Published in:
    2022
    By:
    • Barbanti, Piero;
    • Egeo, Gabriella;
    • Aurilia, Cinzia;
    • Fiorentini, Giulia;
    • Proietti, Stefania;
    • Tomino, Carlo;
    • Bonassi, Stefano;
    • for the Italian Migraine Registry Study Group;
    • Albanese, Maria;
    • Allais, Giovanni;
    • Altamura, Claudia;
    • Aguggia, Marco;
    • Autunno, Massimo;
    • Balsamo, Patrizia;
    • Bartoli, Marco;
    • Bloise, Maria;
    • Benedetto, Chiara;
    • Bono, Francesco;
    • Caggia, Giovanni;
    • Camarda, Cecilia
    Publication type:
    journal article
    7
    8

    Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).

    Published in:
    Neurological Sciences, 2020, v. 41, p. 487, doi. 10.1007/s10072-020-04669-y
    By:
    • Vernieri, Fabrizio;
    • Altamura, Claudia;
    • Aurilia, Cinzia;
    • Brunelli, Nicoletta;
    • Egeo, Gabriella;
    • Fofi, Luisa;
    • Costa, Carmelina Maria;
    • Fallacara, Adriana;
    • Favoni, Valentina;
    • Pierangeli, Giulia;
    • Aguggia, Marco;
    • Bertuzzo, Davide;
    • Albanese, Maria;
    • Di Fiore, Paola;
    • Frediani, Fabio;
    • Cevoli, Sabina;
    • Barbanti, Piero
    Publication type:
    Article
    9

    Migraineurs' psychological traits do not influence response to erenumab.

    Published in:
    Neurological Sciences, 2020, v. 41, p. 467, doi. 10.1007/s10072-020-04661-6
    By:
    • Altamura, Claudia;
    • Costa, Carmelinda;
    • Fofi, Luisa;
    • Viticchi, Giovanna;
    • Fallacara, Adriana;
    • Brunelli, Nicoletta;
    • Egeo, Gabriella;
    • Aurilia, Cinzia;
    • Migliore, Simone;
    • Barbanti, Piero;
    • Silvestrini, Mauro;
    • Vernieri, Fabrizio
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II)

    Published in:
    Journal of Neurology, 2025, v. 272, n. 6, p. 1, doi. 10.1007/s00415-025-13095-z
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Doretti, Alberto;
    • d’Onofrio, Florindo;
    • Scatena, Paola;
    • Rinalduzzi, Steno;
    • Vinciguerra, Luisa;
    • Sansone, Mattia;
    • Vecchio, Rosario;
    • Drago, Valeria;
    • Viticchi, Giovanna;
    • Bartolini, Marco;
    • Ranieri, Angelo;
    • Bandettini di Poggio, Monica;
    • Baldisseri, Francesco;
    • Mascarella, Davide;
    • Brusaferri, Fabio;
    • Caputi, Luigi;
    • Messina, Stefano
    Publication type:
    Article
    25

    Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study.

    Published in:
    Journal of Neurology, 2025, v. 272, n. 2, p. 1, doi. 10.1007/s00415-025-12911-w
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Torelli, Paola;
    • Egeo, Gabriella;
    • d’Onofrio, Florindo;
    • Finocchi, Cinzia;
    • Carnevale, Antonio;
    • Viticchi, Giovanna;
    • Russo, Marco;
    • Quintana, Simone;
    • Orlando, Bianca;
    • Fiorentini, Giulia;
    • Messina, Roberta;
    • Bartolini, Marco;
    • Pistoia, Francesca;
    • Filippi, Massimo;
    • Bonassi, Stefano;
    • Cevoli, Sabina;
    • Mannocci, Alice
    Publication type:
    Article
    26

    Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

    Published in:
    2024
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Proietti, Stefania;
    • D'Onofrio, Florindo;
    • Torelli, Paola;
    • Aguggia, Marco;
    • Bertuzzo, Davide;
    • Finocchi, Cinzia;
    • Trimboli, Michele;
    • Cevoli, Sabina;
    • Fiorentini, Giulia;
    • Orlando, Bianca;
    • Zucco, Maurizio;
    • Di Clemente, Laura;
    • Cetta, Ilaria;
    • Colombo, Bruno;
    • di Poggio, Monica Laura Bandettini;
    • Favoni, Valentina;
    • Grazzi, Licia
    Publication type:
    Correction Notice
    27

    Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study.

    Published in:
    Journal of Neurology, 2024, v. 271, n. 5, p. 2605, doi. 10.1007/s00415-024-12192-9
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Proietti, Stefania;
    • Torelli, Paola;
    • d'Onofrio, Florindo;
    • Carnevale, Antonio;
    • Tavani, Sofia;
    • Orlando, Bianca;
    • Fiorentini, Giulia;
    • Colombo, Bruno;
    • Filippi, Massimo;
    • Bonassi, Stefano;
    • Cevoli, Sabina
    Publication type:
    Article
    28

    Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

    Published in:
    Journal of Neurology, 2024, v. 271, n. 5, p. 2434, doi. 10.1007/s00415-023-12103-4
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Proietti, Stefania;
    • D'Onofrio, Florindo;
    • Torelli, Paola;
    • Aguggia, Marco;
    • Bertuzzo, Davide;
    • Finocchi, Cinzia;
    • Trimboli, Michele;
    • Cevoli, Sabina;
    • Fiorentini, Giulia;
    • Orlando, Bianca;
    • Zucco, Maurizio;
    • Di Clemente, Laura;
    • Cetta, Ilaria;
    • Colombo, Bruno;
    • di Poggio, Monica Laura Bandettini;
    • Favoni, Valentina;
    • Grazzi, Licia
    Publication type:
    Article
    29

    Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.

    Published in:
    Journal of Neurology, 2022, v. 269, n. 11, p. 5848, doi. 10.1007/s00415-022-11226-4
    By:
    • Altamura, Claudia;
    • Brunelli, Nicoletta;
    • Marcosano, Marilena;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Lovati, Carlo;
    • Favoni, Valentina;
    • Perrotta, Armando;
    • Maestrini, Ilaria;
    • Schiano Di Cola, Francesca;
    • d'Onofrio, Florindo;
    • Finocchi, Cinzia;
    • Bertuzzo, Davide;
    • Bono, Francesco;
    • Ranieri, Angelo;
    • Albanese, Maria;
    • Messina, Roberta;
    • Doretti, Alberto;
    • Di Piero, Vittorio;
    • Cevoli, Sabina
    Publication type:
    Article
    30
    31

    Familial mesial temporal lobe epilepsy (FMTLE).

    Published in:
    Journal of Neurology, 2008, v. 255, n. 1, p. 16, doi. 10.1007/s00415-007-0653-1
    By:
    • Striano, Pasquele;
    • Gambardella, Antonio;
    • Coppola, Antonietta;
    • Di Bonaventura, Carlo;
    • Bovo, Giogria;
    • Diani, Erica;
    • Boaretto, Francesca;
    • Egeo, Gabriella;
    • Ciampa, Clotilde;
    • Labate, Angelo;
    • Testoni, Stefania;
    • Passarelli, Daniela;
    • Manna, Ida;
    • Sferro, Caterina;
    • Aguglia, Umberto;
    • Caranci, Ferdinando;
    • Giallonardo, Anna Teresa;
    • Striano, Salvatore;
    • Nobile, Carlo;
    • Michelucci, Roberto
    Publication type:
    Article
    32
    33
    34
    35

    Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.

    Published in:
    European Journal of Neurology, 2023, v. 30, n. 1, p. 224, doi. 10.1111/ene.15563
    By:
    • Vernieri, Fabrizio;
    • Brunelli, Nicoletta;
    • Marcosano, Marilena;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Lovati, Carlo;
    • Favoni, Valentina;
    • Perrotta, Armando;
    • Maestrini, Ilaria;
    • Rao, Renata;
    • d'Onofrio, Luigi;
    • Finocchi, Cinzia;
    • Aguggia, Marco;
    • Bono, Francesco;
    • Ranieri, Angelo;
    • Albanese, Maria;
    • Di Piero, Vittorio;
    • Cevoli, Sabina;
    • Altamura, Claudia;
    • Barbanti, Piero
    Publication type:
    Article
    36

    Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study.

    Published in:
    European Journal of Neurology, 2022, v. 29, n. 4, p. 1198, doi. 10.1111/ene.15197
    By:
    • Vernieri, Fabrizio;
    • Altamura, Claudia;
    • Brunelli, Nicoletta;
    • Costa, Carmelina Maria;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Fofi, Luisa;
    • Favoni, Valentina;
    • Lovati, Carlo;
    • Bertuzzo, Davide;
    • d'Onofrio, Florindo;
    • Doretti, Alberto;
    • Di Fiore, Paola;
    • Finocchi, Cinzia;
    • Schiano Di Cola, Francesca;
    • Ranieri, Angelo;
    • Colombo, Bruno;
    • Bono, Francesco;
    • Albanese, Maria;
    • Cevoli, Sabina
    Publication type:
    Article
    37
    38

    GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.

    Published in:
    Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-02068-2
    By:
    • Barbanti, Piero;
    • Egeo, Gabriella;
    • Pistoia, Francesca;
    • Aurilia, Cinzia;
    • Scatena, Paola;
    • Rinalduzzi, Steno;
    • Strumia, Silvia;
    • Salerno, Antonio;
    • Frediani, Fabio;
    • Galli, Andrea;
    • Autunno, Massimo;
    • Di Clemente, Laura;
    • Zucco, Maurizio;
    • Albanese, Maria;
    • Bono, Francesco;
    • Bruno, Pietrantonio;
    • Borrello, Laura;
    • Messina, Stefano;
    • Doretti, Alberto;
    • Ranieri, Angelo
    Publication type:
    Article
    39

    Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial.

    Published in:
    Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04561-1
    By:
    • Caprio, Massimiliano;
    • Moriconi, Eleonora;
    • Camajani, Elisabetta;
    • Feraco, Alessandra;
    • Marzolla, Vincenzo;
    • Vitiello, Laura;
    • Proietti, Stefania;
    • Armani, Andrea;
    • Gorini, Stefania;
    • Mammi, Caterina;
    • Egeo, Gabriella;
    • Aurilia, Cinzia;
    • Fiorentini, Giulia;
    • Tomino, Carlo;
    • Barbanti, Piero
    Publication type:
    Article
    40
    41

    Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study.

    Published in:
    Brain Sciences (2076-3425), 2024, v. 14, n. 7, p. 672, doi. 10.3390/brainsci14070672
    By:
    • Barbanti, Piero;
    • Orlando, Bianca;
    • Egeo, Gabriella;
    • d'Onofrio, Florindo;
    • Doretti, Alberto;
    • Messina, Stefano;
    • Autunno, Massimo;
    • Messina, Roberta;
    • Filippi, Massimo;
    • Fiorentini, Giulia;
    • Rotondi, Cristina;
    • Bonassi, Stefano;
    • Aurilia, Cinzia
    Publication type:
    Article
    42

    Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations.

    Published in:
    Nutrients, 2021, v. 13, n. 7, p. 2307, doi. 10.3390/nu13072307
    By:
    • Di Lorenzo, Cherubino;
    • Ballerini, Giovanna;
    • Barbanti, Piero;
    • Bernardini, Andrea;
    • D'Arrigo, Giacomo;
    • Egeo, Gabriella;
    • Frediani, Fabio;
    • Garbo, Riccardo;
    • Pierangeli, Giulia;
    • Prudenzano, Maria Pia;
    • Rebaudengo, Nicoletta;
    • Semeraro, Grazia;
    • Sirianni, Giulio;
    • Valente, Mariarosaria;
    • Coppola, Gianluca;
    • Cervenka, Mackenzie C.;
    • Spera, Giovanni
    Publication type:
    Article
    43

    Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).

    Published in:
    Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01396-x
    By:
    • Barbanti, Piero;
    • Egeo, Gabriella;
    • Aurilia, Cinzia;
    • d'Onofrio, Florindo;
    • Albanese, Maria;
    • Cetta, Ilaria;
    • Di Fiore, Paola;
    • Zucco, Maurizio;
    • FilippiBonassi, Massimo;
    • Bono, Francesco;
    • Altamura, Claudia;
    • Proietti, Stefania;
    • Bonassi, Stefano;
    • Vernieri, Fabrizio
    Publication type:
    Article
    44

    Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.

    Published in:
    Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01408-w
    By:
    • Ornello, Raffaele;
    • Baraldi, Carlo;
    • Guerzoni, Simona;
    • Lambru, Giorgio;
    • Andreou, Anna P.;
    • Raffaelli, Bianca;
    • Gendolla, Astrid;
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Cevoli, Sabina;
    • Favoni, Valentina;
    • Vernieri, Fabrizio;
    • Altamura, Claudia;
    • Russo, Antonio;
    • Silvestro, Marcello;
    • Valle, Elisabetta Dalla;
    • Mancioli, Andrea;
    • Ranieri, Angelo;
    • Alfieri, Gennaro
    Publication type:
    Article
    45

    Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.

    Published in:
    Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01363-y
    By:
    • Vernieri, Fabrizio;
    • Brunelli, Nicoletta;
    • Messina, Roberta;
    • Costa, Carmelina Maria;
    • Colombo, Bruno;
    • Torelli, Paola;
    • Quintana, Simone;
    • Cevoli, Sabina;
    • Favoni, Valentina;
    • d'Onofrio, Florindo;
    • Egeo, Gabriella;
    • Rao, Renata;
    • Filippi, Massimo;
    • Barbanti, Piero;
    • Altamura, Claudia
    Publication type:
    Article
    46

    Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).

    Published in:
    Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01247-1
    By:
    • Vernieri, Fabrizio;
    • Altamura, Claudia;
    • Brunelli, Nicoletta;
    • Costa, Carmelina Maria;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Fofi, Luisa;
    • Favoni, Valentina;
    • Pierangeli, Giulia;
    • Lovati, Carlo;
    • Aguggia, Marco;
    • d'Onofrio, Florindo;
    • Doretti, Alberto;
    • Di Fiore, Paola;
    • Finocchi, Cinzia;
    • Rao, Renata;
    • Bono, Francesco;
    • Ranieri, Angelo;
    • Albanese, Maria;
    • Cevoli, Sabina
    Publication type:
    Article
    47

    Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.

    Published in:
    Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1351, doi. 10.1111/head.14194
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Cevoli, Sabina;
    • Egeo, Gabriella;
    • Fofi, Luisa;
    • Messina, Roberta;
    • Salerno, Antonio;
    • Torelli, Paola;
    • Albanese, Maria;
    • Carnevale, Antonio;
    • Bono, Francesco;
    • D'Amico, Domenico;
    • Filippi, Massimo;
    • Altamura, Claudia;
    • Vernieri, Fabrizio;
    • Colombo, Bruno;
    • Frediani, Fabio;
    • Mercuri, Bruno;
    • D'Onofrio, Florindo;
    • Grazzi, Licia
    Publication type:
    Article
    48

    Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project.

    Published in:
    Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 936, doi. 10.1111/head.14123
    By:
    • Barbanti, Piero;
    • Fofi, Luisa;
    • Grazzi, Licia;
    • Vernieri, Fabrizio;
    • Camarda, Cecilia;
    • Torelli, Paola;
    • Cevoli, Sabina;
    • Russo, Antonio;
    • Bono, Francesco;
    • Finocchi, Cinzia;
    • Rao, Renata;
    • Messina, Stefano;
    • De Simone, Roberto;
    • Vanacore, Nicola;
    • Bonassi, Stefano;
    • Egeo, Gabriella;
    • Aurilia, Cinzia;
    • D'Amico, Domenico;
    • Altamura, Claudia;
    • Quintana, Simone
    Publication type:
    Article
    49

    Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study.

    Published in:
    Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 2, p. 363, doi. 10.1111/head.14032
    By:
    • Barbanti, Piero;
    • Aurilia, Cinzia;
    • Egeo, Gabriella;
    • Fofi, Luisa;
    • Cevoli, Sabina;
    • Colombo, Bruno;
    • Filippi, Massimo;
    • Frediani, Fabio;
    • Bono, Francesco;
    • Grazzi, Licia;
    • Salerno, Antonio;
    • Mercuri, Bruno;
    • Carnevale, Antonio;
    • Altamura, Claudia;
    • Vernieri, Fabrizio
    Publication type:
    Article
    50

    Migraine as a Cortical Brain Disorder.

    Published in:
    Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 9, p. 2103, doi. 10.1111/head.13935
    By:
    • Barbanti, Piero;
    • Brighina, Filippo;
    • Egeo, Gabriella;
    • Di Stefano, Vincenzo;
    • Silvestro, Marcello;
    • Russo, Antonio
    Publication type:
    Article